advertisement
 

  Back to Current Daily Care News Daily Care News from 2010

Daily Care News from 2010

    29 December 2010

  1. [New!] One year follow-up in a group of half-marathon runners with type-1 diabetes treated with insulin analogues.
  2. [New!] Coping with stress in adolescents with type 1 diabetes and their mothers.
  3. [New!] Hypoglycemia risk and glucose variability indices derived from routine self-monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counterregulation.
  4. [New!] Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone.

    22 December 2010

  5. Needle Anxiety in Children With Type 1 Diabetes and Their Mothers.
  6. A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus.
  7. Self-classification as an adult in patients with type 1 diabetes: Relationships with glycemic control and illness coping.
  8. Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study.

    15 December 2010

  9. Survey of Insulin Site Rotation in Youth With Type 1 Diabetes Mellitus.
  10. Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy.
  11. School-based lived experiences of adolescents with type 1 diabetes: a preliminary study.
  12. Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland.
  13. Health inequity in children and youth with chronic health conditions.

    8 December 2010

  14. Clinical Performance of Three Bolus Calculators in Subjects with Type 1 Diabetes Mellitus: A Head-to-Head-to-Head Comparison.
  15. Neurocognitive Differences Between Drivers with Type 1 Diabetes with and without a Recent History of Recurrent Driving Mishaps.
  16. Prevalence of Tobacco Use and Association between Cardiometabolic Risk Factors and Cigarette Smoking in Youth with Type 1 or Type 2 Diabetes Mellitus.
  17. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.
  18. The risk factors of ketoacidosis in children with newly diagnosed type 1 diabetes mellitus.
  19. Dose Adjustment for Normal Eating: A qualitative longitudinal exploration of the food and eating practices of type 1 diabetes patients converted to flexible intensive insulin therapy in the UK.
  20. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
  21. Ovulation rate in adolescents with type 1 diabetes mellitus.

    1 December 2010

  22. Multicenter, open-label, nonrandomized, observational safety study in subjects using insulin aspart in basal-bolus regimen for the treatment of diabetes.
  23. Assessment of physical fitness in children and teenagers with type 1 diabetes.
  24. Cardiovascular and metabolic outcome in 6-8year old offspring of women with type 1 diabetes with near-optimal glycaemic control during pregnancy.
  25. Using a Cell Phone-Based Glucose Monitoring System for Adolescent Diabetes Management.
  26. Menstrual irregularities linked to type 1 diabetes.

    24 November 2010

  27. Parent stress and child behaviour among young children with type 1 diabetes.
  28. Correspondence related to Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes.
  29. Retrospective study of the maternal, fetal and perinatal outcomes in diabetic women in twenty years of assistance in the Universidade Federal do Triângulo Mineiro School Hospital.

    17 November 2010

  30. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Free full text available in HTML format.
  31. Hypoglycemia and safe driving. Free full text available in HTML format.
  32. Efficacy and Harms of the Hypoglycemic Agent Pramlintide in Diabetes Mellitus. Free full text available in HTML and PDF formats.

    10 November 2010

  33. Metabolic Demand of Driving Among Adults with Type 1 Diabetes Mellitus (T1DM).
  34. Assessing treatment barriers in young adults with type 1 diabetes.
  35. Bone metabolic abnormalities associated with well-controlled type 1 diabetes (IDDM) in young adult women: a disease complication often ignored or neglected.
  36. Permanent neonatal diabetes mellitus - the importance of diabetes differential diagnosis in neonates and infants.

    3 November 2010

  37. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.
  38. Vitamin D Deficiency and Coronary Artery Calcification in Subjects with Type 1 Diabetes.
  39. Self-management problem solving for adolescents with type 1 diabetes: Intervention processes associated with an Internet program.

    27 October 2010

  40. Clinical Experience with Insulin Glargine in Type 1 Diabetes.
  41. Maternal immune system adaptation to pregnancy - a potential influence on the course of diabetic retinopathy.
  42. Lost in transition? Access to and uptake of adult health services and outcomes for young people with type 1 diabetes in regional New South Wales.

    20 October 2010

  43. Diabetes, insulin treatment, and cancer risk: what is the evidence? Free full text available in HTML and PDF formats.
  44. AAO: Anti-VEGF Drugs Making Leap to Diabetic Eye Disease.

    13 October 2010

  45. Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately.
  46. Parental Involvement and Adolescents' Diabetes Management: The Mediating Role of Self-Efficacy and Externalizing and Internalizing Behaviors.
  47. Assessment of self-reported self-esteem in healthy and diabetic children and adolescents in Greece.
  48. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes.
  49. Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes : Alveolar-capillary membrane conductance in type 1 diabetes.
  50. Therapeutic alliance and glycaemic control in type 1 diabetes: A pilot study.
  51. Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999 - 2004.
  52. Prevalence of gastroparesis in type 1 diabetes mellitus and its relationship to dyspeptic symptoms.

    6 October 2010

  53. Long-Term Insulin Pump Treatment in Girls with Type 1 Diabetes and Eating Disorders - Is It Feasible?
  54. Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of 'living with a machine'.
  55. Insights from a Large Observational Database of Continuous Glucose Monitoring Adoption, Insulin Pump Usage and Glycemic Control: The CareLink™ Database.
  56. HbA(1c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study.
  57. Cardiovascular fitness and quality of life in adolescents with type 1 or type 2 diabetes.
  58. The impact of telemedicine interventions involving routine transmission of blood glucose data with clinician feedback on metabolic control in youth with type 1 diabetes: a systematic review and meta-analysis.
  59. Ten-Year Change in Vision-Related Quality of Life in Type 1 Diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy.
  60. Menopause in women with type 1 diabetes.

    29 September 2010

  61. Continuous glucose monitoring reduces both hypoglycaemia and HbA(1c) in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump.
  62. Factors affecting improved glycaemic control in youth using insulin pumps.
  63. Fear of hypoglycaemia in adults with Type 1 diabetes.
  64. EASD: Pump Plus Glc Monitor Has Low Hypoglycemia Risk.
  65. Hypertension is the Metabolic Syndrome Component Most Strongly Associated with Microvascular Complications and Coronary Artery Calcification in Type 1 Diabetes.
  66. Alexithymia is associated with glycaemic control of children with type 1 diabetes.
  67. Innovations in Participatory Medicine: The Advent of Do-It-Yourself Blood Glucose Monitoring.

    22 September 2010

  68. Medical Expenditures Associated with Diabetes Acute Complications in Privately-Insured U.S. Youth.
  69. EASD: Continuous Monitors May Miss Hypoglycemia.
  70. EASD: Exercise Okay On or Off Pump for T1D Kids.
  71. Parent Report and Direct Observation of Injection-Related Coping Behaviors in Youth with Type 1 Diabetes.
  72. Comparison of puberty and psychosocial adjustment between Taiwanese adolescent females with and without diabetes.
  73. Diabulimia and the role of school health personnel.
  74. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
  75. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes.
  76. Text messaging may increase medical adherence in adolescents with diabetes.
  77. EASD: Frequent Hypoglycemia Key in Cardiac Risk.
  78. Menarchal Timing in Type 1 Diabetes through the Last Four Decades.

    8 September 2010

  79. Continuous Glucose Monitoring Reveals Delayed Nocturnal Hypoglycemia After Intermittent High-Intensity Exercise in Nontrained Patients with Type 1 Diabetes.
  80. Blood glucose levels and performance in a sports cAMP for adolescents with type 1 diabetes mellitus: a field study.
  81. Agility in treatment of children with type 1 diabetes - pilot study.
  82. Gastrointestinal symptoms in type-1 diabetes: Is it all about brain plasticity?
  83. Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus.
  84. Overweight, obesity and metabolic syndrome in children with type 1 diabetes melllitus.
  85. Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication.
  86. Siblings' perceptions of the costs and rewards of diabetes and its treatment.
  87. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes.
  88. Use of Insulin Pumps in India: Suggested Guidelines Based on Experience and Cultural Differences.

    1 September 2010

  89. Perceived Benefits, Barriers, and Strategies of Family Meals among Children with Type 1 Diabetes Mellitus and Their Parents: Focus-Group Findings.
  90. From Caregiver Psychological Distress to Adolescent Glycemic Control: The Mediating Role of Perceived Burden around Diabetes Management.
  91. Dental caries and dental care level (restorative index) in children with diabetes mellitus type 1.
  92. Treatment of patients with diabetic gastroparesis. Free full text available in HTML format.

    25 August 2010

  93. Psychosocial factors associated with use of continuous glucose monitoring.
  94. Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes.
  95. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.
  96. The relationship between the age of onset of type 1 diabetes and the subsequent development of a severe eating disorder by female patients.
  97. Barriers to achieving targets, risks of hyperglycemia and hypoglycemia in children.
  98. Insulin pump therapy: indications and risks - Case 7/2010.
  99. Psychological adjustment of well siblings of children with Type 1 diabetes.
  100. Effect of the carbohydrate counting method on glycemic control in patients with type 1 diabetes.

    18 August 2010

  101. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment.
  102. Type 1 diabetic drivers with and without a history of recurrent hypoglycemia-related driving mishaps: Physiological and performance differences during euglycemia and the induction of hypoglycemia.
  103. Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes. Free full text available in HTML and PDF formats.
  104. Self-efficacy affects blood sugar control among adolescents with type I diabetes mellitus.
  105. Oligomenorrhoea in adolescents with type 1 diabetes mellitus: relationship to glycaemic control.
  106. Medication Utilization and Annual Health Care Costs in Patients With Type 2 Diabetes Mellitus Before and After Bariatric Surgery. See also Bariatric Surgery Resolves [type 2] Diabetes, Saves Money.

    11 August 2010

  107. Quality of Life Measures in Children and Adults with Type 1 Diabetes: The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial.
  108. Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.
  109. Basal Insulin Substitution with Glargine or Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Patients-A Randomized Controlled Trial.
  110. Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden.
  111. Glycemic Variability in Inadequately Controlled Type 1 Diabetes and Type 2 Diabetes on Intensive Insulin Therapy: A Cross-Sectional, Observational Study.

    4 August 2010

  112. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.
  113. Pilot Study for Assessment of Optimal Frequency for Changing Catheters in Insulin Pump Therapy-Trouble Starts on Day 3.
  114. Nonlinear Metabolic Effect of Insulin across the Blood Glucose Range in Patients with Type 1 Diabetes Mellitus.
  115. Bolus Guide: A Novel Insulin Bolus Dosing Decision Support Tool Based on Selection of Carbohydrate Ranges.
  116. Outpatient-to-Inpatient Transition of Insulin Pump Therapy: Successes and Continuing Challenges.
  117. Physical activity and sedentary behavior in adolescents with type 1 diabetes.

    28 July 2010

  118. Sensor-Augmented Insulin-Pump Therapy.
  119. Confirmation of Hypoglycemia in the "dead-in-bed" Syndrome, as Captured by a Retrospective Continuous Glucose Monitoring System, previously reported, now has the full text available in PDF format.
  120. "Dead in bed": a tragic complication of type 1 diabetes mellitus.
  121. Preventing Post-Exercise Nocturnal Hypoglycemia in Children with Type 1 Diabetes.
  122. Physical activity in adolescent females with type 1 diabetes.
  123. Self-efficacy Affects Blood Sugar Control Among Adolescents With Type I Diabetes Mellitus.
  124. Depression is associated with the metabolic syndrome among patients with type 1 diabetes.
  125. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies.
  126. Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007.

    21 July 2010

  127. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. Free full text available in PDF format.
  128. Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial. Free full text available in HTML and PDF formats.
  129. The impact of health insurance coverage on pediatric diabetes management.
  130. Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors.
  131. Gastrointestinal symptoms in adolescents with type 1 diabetes.
  132. Evaluation of the final stature reached by type 1 diabetes mellitus patients followed at an outsourced service.
  133. Changes in pulse pressure, heart rate and the pulse pressure x heart rate product during squatting in Type 1 diabetes according to age.
  134. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.
  135. Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing Regimen.

    14 July 2010

  136. Medtronic Diabetes offers a summary of Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes (the STAR3 trial) in PDF.
  137. Many diabetic patients with recurrent severe hypoglycemias hold a valid driving license. A community-based study in insulin-treated patients with diabetes.
  138. Maturity-onset diabetes of the young (MODY): how many cases are we missing? (PDF).
  139. Doses Of Insulin And Its Analogues And Cancer Occurrence In Insulin-treated Type 2 Diabetic Patients. See also Higher doses of insulin glargine associated with cancer.

    7 July 2010

  140. The impact of baseline hemoglobin A1c levels prior to initiation of pump therapy on long-term metabolic control.
  141. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
  142. Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes.
  143. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the juvenile diabetes research foundation continuous glucose monitoring randomized trial.
  144. Analysis of 24-hour glycemic excursions in patients with type 1 diabetes by using continuous glucose monitoring.
  145. Interventions With Adherence-Promoting Components in Pediatric Type 1 Diabetes Meta-analysis of their impact on glycemic control.
  146. Caffeine May Ward Off Exercise-Related Hypoglycemia in Type 1 Diabetes. (Free Medscape membership required to view.)

    30 June 2010

  147. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes. Free full text available in PDF format. See also Continuous Glucose Monitoring — Coming of Age, also available in PDF format.
  148. Defining the ideal injection techniques when using 5-mm needles in children and adults.
  149. Effects of Glutamine on Glycemic Control During and After Exercise in Adolescents with Type 1 Diabetes Mellitus (T1DM): a Pilot Study.

    23 June 2010

  150. The mediating role of extreme peer orientation in the relationships between adolescent-parent relationship and diabetes management.
  151. Health-related quality of life (HRQoL) of children with type 1 diabetes mellitus (T1DM): self and parental perceptions.
  152. Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web-survey.
  153. Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with Type 1 diabetes?
  154. What do Youth with Type 1 Diabetes Know about the HbA1c Test?
  155. Is bedtime supper necessary for older children with diabetes using glargine insulin in multiple daily injection regimens?
  156. Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus.
  157. Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring.

    16 June 2010

  158. Dose adjustment for normal eating (DAFNE) - an audit of outcomes in Australia.
  159. An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog. Free full text available in HTML and PDF formats.
  160. Polyendocrinopathy in children, adolescents and young adults with type 1 diabetes. A multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss-database.
  161. Isomaltulose Improves Post-Exercise Glycemia by Reducing CHO Oxidation in T1DM.

    9 June 2010

  162. Immunogenicity of different brands of human insulin and rapid-acting insulin analogs in insulin-naïve children with type 1 diabetes.
  163. Basal Insulin Requirements on Continuous Subcutaneous Insulin Infusion During the First 12 Months After Diagnosis of Type 1 Diabetes Mellitus.
  164. Relationship between nutrition factors and glycemic control in children and adolescents with type 1 diabetes mellitus.
  165. Practical Considerations in the Use of Real-Time Continuous Glucose Monitoring Alerts.
  166. A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency.
  167. Perceived family burden and emotional distress: similarities and differences between mothers and fathers of children with type 1 diabetes in a population-based study.

    2 June 2010

  168. Enhanced Algorithm for glucose estimation using the Continuous Glucose Monitoring System.
  169. Relationship hypertension-microalbuminuria in type 1 diabetes.
  170. Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes.
  171. Long-term mortality and retinopathy in type 1 diabetes.
  172. A multi-disciplinary education process related to the discharging of children from hospital when the child has been diagnosed with type 1 diabetes - a qualitative study. Free full text available in HTML and PDF formats.

    26 May 2010

  173. Mixing Insulin Aspart With Detemir Does Not Affect Glucose Excursion In Children With Type 1 Diabetes Mellitus.
  174. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention.
  175. Insufficient long-term glycemic control is associated with multifocal ERG defects in adolescents with Type 1 Diabetes.
  176. Oral Health Knowledge and Behaviors among Adolescents with Type 1 Diabetes. Free full text available in HTML and PDF formats.
  177. Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes.
  178. QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction.
  179. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study.
  180. Excess Health Care Costs of Obesity in Adults with Diabetes Mellitus: a Claims Data Analysis.

    19 May 2010

  181. Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus.
  182. Three-year follow up of metabolic control in adolescents with type 1 diabetes with and without eating disorders.
  183. Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial.
  184. Psychological adjustment to diabetes mellitus: highlighting self-integration and self-regulation.

    12 May 2010

  185. Responsibility Sharing between Adolescents with Type 1 Diabetes and Their Caregivers: Importance of Adolescent Perceptions on Diabetes Management and Control.
  186. Shared and individual medical appointments for children and adolescents with type 1 diabetes; differences in topics discussed?
  187. Carbohydrate counting improves coping ability and metabolic control in patients with Type 1 Diabetes managed by Group Care.
  188. Racial Disparity in A1C Independent of Mean Blood Glucose in Children With Type 1 Diabetes. See also Diabetes test may fail black children.
  189. Risks of marathon running and hypoglycaemia in Type 1 diabetes.
  190. Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration.
  191. Bone status in adolescents with type 1 diabetes.
  192. Physical Activity and Electronic Media Use in The SEARCH for Diabetes in Youth Case-Control Study.

    5 May 2010

  193. Blood Glucose Monitoring and Glycemic Control in Adolescence: Contribution of Diabetes-Specific Responsibility and Family Conflict.
  194. Relation of fasting and postprandial and plasma glucose with hemoglobinA1c in diabetics. Free full text available in HTML format.
  195. Cumulative risk, age at onset and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes. A nationwide population based cohort study.
  196. Glycemic control and cardiovascular disease in 7454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
  197. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.
  198. Glycemic control in children with Type 1 diabetes in Wales: the influence of the Pediatric Diabetes Specialist Nurse.
  199. Redefining relationships and identity in young adults with type 1 diabetes.
  200. Supporting parents of very young children with type 1 diabetes: Results from a pilot study.
  201. Survival of patients with type 1 diabetes on renal replacement therapy in 1980-2007.
  202. Exenatide Affected Circulating Cardiovascular Risk Biomarkers Independently Of Changes In Body Composition.

    28 April 2010

  203. Age-Related Differences in the Frequency of Ketoacidosis at Diagnosis of Type 1 Diabetes in Children and Adolescents.
  204. New insulin analogues and perioperative care of patients with type 1 diabetes.
  205. Factors Associated With Cesarean Delivery in Nulliparous Women With Type 1 Diabetes. See also Weight Plays Part in C-Section in Type 1 Diabetes.
  206. Perception of the impact of type 1 diabetes on low-income families.
  207. 21 April 2010

  208. Comparison of the clinical information provided by the FreeStyle Navigator continuous interstitial glucose monitor versus traditional blood glucose readings.
  209. Equal metabolic control but superior caregiver treatment satisfaction with insulin aspart in preschool children.
  210. Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes.
  211. 14 April 2010

  212. Improving glycaemic control in children and adolescents: which aspects of therapy really matter?
  213. Temporal patterns in overweight and obesity in Type 1 diabetes.
  214. Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study.
  215. Adolescents with type 1 diabetes and risky behaviour.
  216. Computer's use, free time activities and metabolic control in patients with type 1 diabetes.
  217. Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes.
  218. Detection of Surreptitious Administration of Analog Insulin to an 8-Week-Old Infant.
  219. Prime-Time Hypoglycemia: Factitious Hypoglycemia During Insulin-Pump Therapy.
  220. Early Risk Factors for Nonadherence in Pediatric Type 1 Diabetes: A Review of the Recent Literature.
  221. 7 April 2010

  222. Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control.
  223. Partial sleep restriction decreases insulin sensitivity in type 1 diabetes.
  224. Glycemic Control, Coping, and Internalizing and Externalizing Symptoms in Adolescents with Type 1 Diabetes: A Cross-Lagged Longitudinal Approach.
  225. Glycemic Control in Pediatric Type 1 Diabetes: Role of Caregiver Literacy.
  226. Psychosocial well-being and functional outcomes in youth with type 1 diabetes 12 years after disease onset.
  227. The Structure of Parental Involvement and Relations to Disease Management for Youth with Type 1 Diabetes.

    31 March 2010

  228. Use of continuous glucose monitoring in young children with type 1 diabetes: implications for behavioral research.
  229. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes.
  230. Predictors of metabolic control in children with Type 1 diabetes: The impact of Hurricane Katrina in a prospective study.
  231. Optimal timing of insulin detemir injection in patients with type 1 diabetes and poor metabolic control.
  232. Dental caries and adolescents with type 1 diabetes.
  233. Verbal and academic skills in children with early-onset type 1 diabetes.
  234. Diabetic mothers and their newborn infants - rooming-in and neonatal morbidity.
  235. Perceived Access to Contraception Among Adolescents With Diabetes: Barriers to Preventing Pregnancy Complications.
  236. Effect on carbohydrate metabolism and analysis of acceptability (menstrual cycle control) of extended regimens of the vaginally inserted hormone-releasing system 'NuvaRing' as compared with the standard 21/7 regime in reproductive-age women with type 1 diabetes mellitus.

    24 March 2010

  237. The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes.
  238. Relation of stressful life events to metabolic control among adolescents with diabetes: 5-year longitudinal study.
  239. The shape of the metabolic memory of HbA(1c): re-analysing the DCCT with respect to time-dependent effects.
  240. The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes.

    17 March 2010

  241. Parental Involvement Buffers Associations Between Pump Duration and Metabolic Control among Adolescents with Type 1 Diabetes.
  242. Overweight Is Highly Prevalent In Children with Type 1 Diabetes And Associates with Cardiometabolic Risk.
  243. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
  244. Association between metabolic control and oral health in adolescents with type 1 diabetes mellitus.
  245. Diabetic ketoacidosis at diagnosis in Austrian children in 1989-2008: a population-based analysis.
  246. Insulin pump therapy in moslem patients with type 1 diabetes during ramadan fasting: an observational report.
  247. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
  248. Asymmetric Large-for-Gestational-Age Infants of Type 1 Diabetic Women: Morbidity and Abdominal Growth.

    10 March 2010

  249. Prolonged Nocturnal Hypoglycemia Is Common During 12 Months Of Continuous Glucose Monitoring In Children And Adults With Type 1 Diabetes.
  250. Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension.
  251. Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Non-obese, Non-diabetic Individuals.
  252. Evaluation of an Algorithm to Guide Patients with Type I Diabetes Treated with Continuous Subcutaneous Insulin Infusion (CSII) on How to Respond to Real-Time Continuous Glucose Levels- A Randomised Control Trial.
  253. Renal Doppler indices in diabetic children with insulin resistance syndrome.
  254. Metabolic Control, Self-care Behaviors, and Parenting in Adolescents With Type 1 Diabetes: A Correlational Study.
  255. Executive Functioning, Treatment Adherence, and Glycemic Control in Children with Type 1 Diabetes.
  256. Bilateral carpal tunnel syndrome in a child with type 1 diabetes mellitus.

    3 March 2010

  257. Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes.
  258. Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes.
  259. Racial Disparity in Hemoglobin A1c Independent of Mean Blood Glucose in Children with Type 1 Diabetes.
  260. Health related quality of life, treatment satisfaction and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes. A randomized controlled trial.
  261. Development of an Internet Coping Skills Training Program for Teenagers With Type 1 Diabetes.
  262. Characteristics of self-regulation in adolescent girls with Type 1 diabetes with and without eating disorders: A cross-sectional study.
  263. Brief Report: Trajectories of Glycemic Control over Early to Middle Adolescence.
  264. Age at onset and the risk of proliferative retinopathy in type 1 diabetes.
  265. Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus.
  266. Antioxidant enzyme activities and DNA damage in children with type 1 diabetes mellitus after 12 weeks of exercise.
  267. Down's syndrome in diabetic patients aged <20 years: an analysis of metabolic status, glycaemic control and autoimmunity in comparison with type 1 diabetes.
  268. Insulin Usage with the Risk of Cancer in Type 2 Diabetes – the Hong Kong Diabetes Registry.

    24 February 2010

  269. Alarm Characterization for Continuous Glucose Monitors Used as Adjuncts to Self-Monitoring of Blood Glucose.
  270. Alarm Characterization for a Continuous Glucose Monitor That Replaces Traditional Blood Glucose Monitoring.
  271. Telehealth Behavior Therapy for the Management of Type 1 Diabetes in Adolescents.
  272. Normal-range albuminuria does not exclude nephropathy in diabetic children.
  273. Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy.

    17 February 2010

  274. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
  275. The use of Rapid-Acting insulin Analogs in Basal-Bolus Regimens in type 1 Diabetes.
  276. The early pharmacodynamic and pharmacokinetic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes.
  277. Effect Of Prior Intensive Insulin Treatment During The Diabetes Control And Complications Trial (DCCT) On Peripheral Neuropathy In Type 1 Diabetes During The Epidemiology Of Diabetes Interventions, And Complications (EDIC) Study.
  278. Effect of Prior Intensive Therapy in Type 1 Diabetes Mellitus on 10-year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and Adolescents.
  279. Hemoglobin A1c is a reliable criterion for diagnosing type 1 diabetes in childhood and adolescence.

    10 February 2010

  280. Measurement delay associated with the Guardian(R) RT continuous glucose monitoring system.
  281. Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study.
  282. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
  283. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis.
  284. Long-Term Results of Gastric Bypass Surgery in Morbidly Obese Type 1 Diabetes Patients.

    3 February 2010

  285. Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study).
  286. Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients.
  287. Insulin-sensitivity response to a single bout of resistive exercise in type 1 diabetes mellitus.
  288. Effect of Insulin Analogs on the Decline of Hemoglobin in Diabetic Patients with Nephropathy.

    27 January 2010

  289. Correlates of Insulin Injection Omission. See also 57% of diabetics occasionally skip insulin shots on purpose.
  290. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients.
  291. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.
  292. Attitudes towards insulin pump therapy among adolescents and young people.
  293. Siphon Effects on Continuous Subcutaneous Insulin Infusion Pump Delivery Performance (PDF). See also Changes in the Position of Conventional Insulin Pumps Shown to Significantly Impact Accuracy of Insulin Delivery.
  294. Continuous Glucose Monitoring during Exercise in Patients with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion (PDF).
  295. Individuals Achieve More Accurate Results with Meters That Are Codeless and Employ Dynamic Electrochemistry (PDF).
  296. Prevalence of Increased Arterial Stiffness in Children with Type 1 Diabetes Mellitus Differs by Measurement Site and Sex: The SEARCH for Diabetes in Youth Study.
  297. Risk Factors Associated with Depressive Symptoms in Caregivers of Children with Type 1 Diabetes or Cystic Fibrosis.
  298. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.

    20 January 2010

  299. Skipping Meals or Carbohydrate-Free Meals in Order to Determine Basal Insulin Requirements in Subjects with Type 1 Diabetes Mellitus?
  300. Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes.
  301. Utility of immediate hemoglobin A1c in children with type I diabetes mellitus.
  302. When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009.
  303. Medicine and Judaism--a patient is forbidden to endanger his life in order to fast on Yom Kippur.

    13 January 2010

  304. The dual-wave bolus feature in type 1 diabetes adult users of insulin pumps.
  305. How Much Do I Give? Reevaluation of Insulin Dosing Estimation Formulas Using Continuous Glucose Monitoring.
  306. Euglycemic infusion of insulin detemir compared to human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects.
  307. The use of metformin in type 1 diabetes: a systematic review of efficacy.
  308. Maternal overweight and pregnancy outcome in women with Type-1 diabetes mellitus and different degrees of nephropathy.
  309. Stress among fathers of young children with type 1 diabetes.
  310. The "Cough Trick," a Brief Strategy to Manage Pediatric Pain From Immunization Injections.

    6 January 2010

  311. Comparison of the dose accuracy of prefilled insulin pens.
  312. Coordinated Basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy.
  313. Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?
  314. Self-Monitoring of Blood Glucose in Type 1 Diabetes Patients with Insufficient Metabolic Control: Focused Self-Monitoring of Blood Glucose Intervention Can Lower Glycated Hemoglobin A1C.
  315. The narrative-autobiographical approach in the group education of adolescents with diabetes: A qualitative research on its effects.
  316. Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the U.S. Continues to Decline. Free full text available in HTML and PDF formats.

[ Current Daily Care News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Home Return to Top

Last Updated: Thursday January 01, 2015 15:28:57
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.